Guidelines for Evaluation and Management of Iron Deficiency Anemia in Women > 65 Years

Evaluation Before Iron Supplementation

• Routine iron supplementation in women > 65 years should not be given without a full gastrointestinal work‑up, because iron‑deficiency anemia in this age group is uncommon and often signals serious pathology such as gastrointestinal bleeding or malignancy. Strong recommendation. 1
• Bidirectional endoscopy (upper endoscopy + colonoscopy) is strongly recommended for all post‑menopausal women with iron‑deficiency anemia, given the markedly increased risk of gastrointestinal malignancy with advancing age. Strong recommendation. 2
• Celiac disease screening with tissue transglutaminase antibodies should be performed in every patient, regardless of symptoms, because celiac disease accounts for up to 4 % of iron‑deficiency cases. Moderate recommendation. [2][3]
• Helicobacter pylori testing should be done non‑invasively before endoscopic evaluation. Moderate recommendation. 2
• Epidemiology: Iron‑deficiency anemia occurs in only ≈2 % of women ≥ 50 years; among those, ≈62 % have gastrointestinal bleeding lesions and ≈66 % have chronic disease or inflammatory conditions as the primary cause. Evidence level: observational data. [4][1]

Diagnostic Criteria

• Hemoglobin < 12 g/dL in non‑pregnant women is the threshold for suspecting iron deficiency. Evidence level: guideline consensus. 2
• Serum ferritin < 45 ng/mL is the most powerful single diagnostic cutoff for iron deficiency. Evidence level: guideline consensus. 2
• Ferritin values must be interpreted in the context of inflammatory states, as ferritin is an acute‑phase reactant. Evidence level: guideline consensus. 2

Oral Iron Therapy (First‑Line)

• Vitamin C 500 mg should be taken with each iron dose to enhance absorption. Evidence level: randomized trial. 3
• After achieving a normal hemoglobin, continue oral iron for 3 months to fully replenish iron stores. Evidence level: randomized trial. 3
• Monitoring schedule: check hemoglobin every 3 months for 1 year, then annually, and only if symptoms recur. Evidence level: guideline consensus. 3
• Aim for a target ferritin > 100 ng/mL to confirm adequate repletion of iron stores. Evidence level: guideline consensus. 3

Intravenous Iron Therapy

• IV iron is indicated when any of the following occur:
  Evidence level: guideline consensus. 3

Safety, Dosing Considerations, and Monitoring in the Elderly

• Low‑dose oral iron (≤ 50 mg elemental iron daily) should be used in vulnerable elderly patients to reduce gastrointestinal side‑effects. Evidence level: cohort study. 5
• Regular monitoring of iron status is essential to prevent iron overload. Evidence level: cohort study. 5
• Do not prescribe iron when anemia is not attributable to iron deficiency, as it offers no benefit and increases toxicity risk. Evidence level: cohort study. 5
• Clinicians should avoid assuming dietary deficiency as the cause of anemia in post‑menopausal women; chronic disease and gastrointestinal pathology are far more common etiologies. Evidence level: observational data. [4][1]

Management of Iron Deficiency Anemia

Diagnostic Approach

• The American Gastroenterological Association recommends that women over 45 years require full gastrointestinal investigation, including upper endoscopy with small bowel biopsies and colonoscopy, as the risk of serious pathology increases significantly with age 6, 7
• All patients should be screened for celiac disease, regardless of age, as this is a common cause of iron malabsorption 7, 8
• Serum ferritin is the most powerful test for iron deficiency, with a threshold of <45 mg/dL recommended for diagnosis 7, 9

Iron Replacement Therapy

• The European Society of Gastroenterology recommends starting with ferrous sulfate 200 mg once daily, containing 65 mg elemental iron, which is the simplest and most cost-effective option 6, 8, 10
• Adding vitamin C 500 mg with each iron dose enhances absorption 6, 10
• Hemoglobin should rise by 2 g/dL after 3-4 weeks of treatment, and oral iron should be continued for 3 months after hemoglobin normalizes to replenish iron stores 6, 8, 10

Intravenous Iron Therapy

• The American College of Gastroenterology recommends intravenous iron therapy for patients who are intolerant to at least two different oral iron preparations, have a contraindication to oral iron, or have ineffective oral iron 8, 10
• Modern IV iron formulations can replace iron deficits with 1-2 infusions rather than multiple infusions 10

Special Considerations

• The National Institute for Health and Care Excellence recommends that women under 45 years without upper GI symptoms do not routinely need upper endoscopy, but should have celiac screening 6
• Hemoglobin <10 g/dL in women suggests more serious disease requiring urgent investigation 7

Common Pitfalls to Avoid

• The American Gastroenterological Association recommends avoiding excessive daily doses (>200 mg elemental iron) as this increases side effects and paradoxically reduces absorption due to hepcidin elevation 8, 10
• The European Society of Gastroenterology recommends not prematurely discontinuing iron before stores are replenished, as this leads to rapid recurrence 10